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Abstract 
Introduction: Depressive symptoms occur frequently in people with Multiple Sclerosis (MS) 
and rates of suicide ideation are higher than the general population.  There is evidence for a 
direct association between disability and depression, disability and suicide ideation, and 
depression and suicide ideation in MS.  However, the relationship between all three, i.e. the 
mediating role of depression between disability and suicidal ideation, has not been 
investigated.  Exploring this relationship could highlight risk factors, alerting clinicians to the 
need for timely intervention. 
Method: Seventy five people with progressive MS attending two out-patient clinics took part 
in this cross-sectional study.  Participants completed the Beck Suicide Scale, Beck 
Depression Inventory, Multiple Sclerosis Impact Scale and Guy’s Neurological Disability 
Scale. 
Results: Depressive symptoms mediated the relationship between perceived and actual 
disability and suicide ideation.  Different types of disability were associated with suicidality, 
including: ‘tremors’ and ‘taking longer to do things’.  A small sub-group of participants were 
identified who reported suicide ideation in the presence of only mild levels of depression. 
Limitations: There may be a sample bias in this study as all participants were attending out-
patient clinics and receiving support which may not be available to everyone with MS.  
Conclusion:  It is important for clinicians to screen regularly for both depression and suicide 
ideation, to be alert to specific types of disability for which a higher level of suicide ideation 
might be present and to consider the possibility of suicidal thoughts being present in people 
who show minimal or no depressive symptoms.      
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Background 
MS is a progressive, neurodegenerative, immune-mediated disorder, characterised by 
deterioration of the myelin sheath (Pugliatti et al., 2006).  The disease course is most often 
categorised into three different types referred to as: relapsing remitting MS (RRMS), primary 
progressive MS (PPMS) and secondary progressive MS (SPMS); irrespective of type, 
symptoms can vary considerably.  Primary progressive MS (PPMS) encompasses increasing 
disability from onset with plateaus and possible minor improvements (Pugliatti et al., 2006).  
Secondary progressive MS (SPMS) is diagnosed if a progressive disease course follows a 
period of symptomatic relapses originally referred to as relapsing remitting MS (RRMS) 
(Tutuncu et al., 2012).  Two thirds (approximately) of those diagnosed with RRMS will 
transition to SPMS, usually 10-15 years after diagnosis (Hooper, 2013).  The rate of disease 
progression in both PPMS and SPMS has been found to be comparable (Kuhlman, 2013; 
Soldán et al., 2015).  In progressive MS types, where there is a higher level of increasing 
disability compared to RRMS, this has been associated with higher levels of depression and 
suicide ideation (Chwastiak et al., 2002; Dennis et al., 2009; Sarısoy, Terzi, Gümüş, & 
Pazvantoğlu, 2013; Turner et al., 2006).  For this reason, progressive MS types will be the 
focus of investigation in this research study. 
Depressive symptoms occur frequently in people with Multiple Sclerosis (MS) 
(Dalgas et al., 2014) and are considered to be a significant problem in this condition (Gay, 
Vrignaud, Garitte & Meunier, 2010).  The risk of depressive symptoms in MS has been found 
to be as high as 50% (Chwastiak et al., 2002).  This is four times higher than the risk of 
depression reported in the general population (Ayuso-Mateos et al., 2001).  Suicide rates in 
the MS population have been found to be twice the rate of the general population (Bronnum-
Hansen, Stenager, Stenager & Kock-Henriksen, 2005) and it has been reported that over a 
quarter of people with MS experience suicide ideation (Feinstein, 2002).  
 Depression in MS has been shown to be highly correlated with suicidality (Carson, 
Best, Warlow & Sharpe, 2000)  but depressive symptoms are often undetected and untreated 
(Feinstein, 2004; Patten, Beck, Williams, Barbui & Metz, 2003).  This may be due to a 
difficulty in distinguishing depression from the common symptoms of MS, for example, 
fatigue and cognitive dysfunction, both of which can be observed in MS without the presence 
of depressive symptoms (Siegert & Abernethy, 2005).  Alternatively, Caine and Schwid 
(2002) suggest that suicide ideation in MS may not be identified because patients tend to 
minimise these thoughts during assessment in order to provide superficial reassurance to their 
clinicians that they will not harm themselves.   
Suicide ideation in people with disabilities is a complex and imperative health 
concern (Giannini et al., 2010).  Not only is depression a key predictor of suicide risk in MS 
(Paparrigopoulos, Ferentinos, Kouzoupis, Koutsis & Papadimitriou, 2010) but the presence of 
depression is known to have a significant impact upon quality of life, general health 
(Feinstein, 2007; Lester, Stepleman & Hughes, 2007) and adherence to treatment (Mohr, 
Goodkin, Gatto & Van Der Wende, 1997).  Attending to depression and suicidality in MS is 
therefore, a medical priority, to the extent that suicide may be an avoidable tragedy (Faber, 
2003).   
Disability (impairments in body structure or function and activity limitation, with one 
study measuring participation level, as defined by the World Health Organisation, 2002) in 
MS has been found to have an impact upon both depression and suicide ideation when 
explored separately.  No existing research has investigated the interrelationship between all 
three variables.  Therefore, the present study will explore whether depression mediates the 
relationship between disability and suicidal ideation.  
The direct relationship between depressive symptoms and disability was considered in 
a systematic review by Arnett, Barwick and Beeney (2008) and resulted in equivocal 
findings.  For the majority of studies included in the review, the measure of disability was the 
Expanded Disability Status Scale (EDSS) developed by Kurtzke (1983) which measures 
impairments in the following functional systems: pyramidal (ability to walk), cerebellar 
(coordination), brain stem (speech and swallowing), sensory (touch and pain), bladder and 
bowel, visual, mental and any other neurological symptoms caused by MS.  Other measures 
utilised were the Sickness Impact Profile (SIP), physical summary subscale (Bergner, 
Bobbitt, Carter, and Gilson, 1981) which measures somatic autonomy and mobility control; 
and the London Handicap Scale (LHS) (Harwood and Ebrahim, 1995) which measures 
mobility, physical independence, occupation, social integration, orientation and economic 
self-sufficiency.  All measures provide a total score and the higher the score the higher the 
level of disability.  
Null findings were reported in eleven studies but five of these had a small sample size 
(ranging from n = 10 - 50).  Five studies had a reasonable sample size (ranging from n = 83 - 
98) using standard measures of disability and depression.  One other study used a non-
standardised measure of disability.  Conversely, eleven studies reported statistically 
significant findings, all suggesting a positive correlation between disability and depression, 
with effect sizes in the moderate range, suggesting increased disability is related to increased 
depression.  All except one used standardised measures, and sample sizes ranged from n = 76 
- 1374 except for two (n = 18 and n = 45).  Since this review, several other studies have 
confirmed this association (Anhoque, Domingues, Carvalho, Teixeira & Domingues, 2011; 
Arnett et al., 2008; Beal et al., 2007; da Silva et al., 2011; Gay et al., 2010; Sarısoy et al., 
2013; Smith & Arnett, 2013). 
With regards to the direct relationship between depressive symptoms and suicide 
ideation in people with MS, this has been explored in three studies (Feinstein, 2002; Viner et 
al. 2014; Turner et al., 2006); one did not find a significant association between level of 
depression and suicide ideation (Feinstein, 2002) and there are methodological weaknesses in 
the two which did find a significant association due to low to moderate response rates: 39.5% 
(Viner et al. 2014) and 43.7% (Turner et al. 2006) and the use of non-standardised measures. 
Feinstein (2002) measured suicide ideation by using just three self-report questions derived 
from the Beck Suicide Scale (Beck and Steer, 1993) and thus the psychometric properties of 
these three questions are unknown.  Similarly, Viner et al. (2014) used a self-designed 
measure of disability rather than a standardised and validated measure and both Turner et al. 
(2006) and Viner et al. (2014) assessed suicide ideation by selecting a single item from the 
Patient Health Questionnaire (PHQ-9) (Kroenke and Spitzer, 2002), and although the 
measure itself is said to have good psychometric properties (Manea, Gilbody, McMillan, 
2015), these are unknown for a single item. 
Looking at the direct relationship between disability and suicide ideation, Feinstein 
(2002) did not find a significant association.  However, two more recent studies reported that 
self-reported bladder or bowel difficulties, and communication and swallowing difficulties 
were risk factors for suicide ideation (Viner et al., 2014, Turner et al., 2006) and in addition, 
Turner et al. (2006) found that mobility problems and a higher level of perceived disability 
was associated with suicide ideation.  Assessing a person’s own perspective of disability is 
important (Turk, Okifuji & Scharff, 1995) and there are an increasing number of studies 
incorporating these measures (Freeman et al., 2001).  For example, it has been found in a 
study exploring obesity related disability, that level of perceived disability can be different 
from actual physical limitation (Larsson & Mattsson, 2001).  Therefore, the present study will 
explore both self-reported disability and the degree to which this is seen as a problem for the 
person.  
Finally, two studies have explored the direct relationship between disability and 
completed suicide in MS during a study of risk factors.  One found that those with a moderate 
level of disability were most at risk (Stenager et al., 1996) and one found that those who were 
more severely disabled were more at risk (Berman & Samuel, 1993).    
As mentioned earlier, the interrelationship disability, depression and suicide ideation 
has not been investigated in the MS population although, Meltzer et al. (2012) found 
depression to mediate the relationship between disability and suicide ideation in the general 
population.  If increasing levels of disability are found to be important, or any specific type of 
disability, found to be a ‘red flag’ for depression and hence suicide, it emphasises the 
importance of screening for both in the future.  Findings could also alert clinicians to the need 
for more timely interventions in order to ameliorate distress. 
A related concept termed ‘rational’ suicide would also benefit from consideration 
within the interrelationship of these three variables.  Although it is well recognised that 
suicide ideation is a core symptom of major depression (Pompili et al., 2012), it has been 
found that in the MS population, not all suicides have occurred in the context of depressive 
symptoms (Sadovnick et al., 1991).  It has been suggested that people can freely desire 
suicide or a hastened death based upon a logical, carefully contemplated decision in the 
absence of depression or psychiatric difficulties (Onkay-Ho, 2014).   
Criteria for ‘rational’ suicide have been defined as: “(i) the presence of an 
unremittingly hopeless condition, (ii) a suicidal decision made as a free choice and (iii) the 
presence of an informed decision-making process” (Werth & Cobia, 1995, p. 1).  In a MS 
specific study by Gaskill, Foley, Kolzet and Picone (2011) a perceived loss of control was 
found to be associated with suicide ideation suggesting that the ideation could provide a fall 
back means of still feeling in control for people faced with the burden of an unpredictable 
disease.  There is no research to date exploring whether there is a sub-group of people with 
suicide ideation with only a minimal or mild level of depression in MS, therefore this will be 
examined in the present study.    
The term disability in this study refers to disability as measured by Guys Neurological 
Disability Scale (GNDS) (Sharrack & Hughes, 1999) (which asks questions about: memory 
and concentration, mood and emotions, vision, speech and communication, swallowing, use 
of the arms and hands, mobility, bladder and bowel function, sexual function and fatigue) or 
perceived disability as measured by the Multiple Sclerosis Impact Scale (MSIS-29) (Hobart, 
Lamping, Fitzpatrick, Riazi & Thompson, 2001) which assesses the physical and 
psychological impact of MS.    
Aims of the current study 
Do depressive symptoms mediate the relationship between perceived disability and suicide 
ideation? 
Do depressive symptoms mediate the relationship between actual disability and suicide 
ideation? 
Based on the work of Turner et al. (2006) and Viner et al. (2014) is any specific type of 
disability related to suicide ideation? 
Based upon the work of Onkay-Ho (2014) is there a sub-group of individuals who report 
suicide ideation with only a minimal or mild level of depressive symptoms? 
Methods 
 A cross-sectional study design was utilised.  Ethics approval was received from the 
West Midlands branch of National Research Ethics Committee.  
Participants 
 Participants were recruited from two MS clinics in Birmingham.  The first was an 
interdisciplinary specialist rehabilitation clinic for people with MS who have complex needs 
in terms of disability management.  The second clinic was a specialist MS clinic in an acute 
hospital which monitored all patients in the local area with MS.   
Inclusion criteria:  
1. A diagnosis of progressive MS following neurological examination, cerebrospinal fluid 
(CSF) examination or magnetic resonance imaging (MRI) and determined by the McDonald 
criteria (Polman et al., 2011).   
2. Ability to provide informed consent to participate in the study. 
3. Sufficient command of English language to complete the study measures with the 
researcher. 
4. Age at least 16 years. 
 
Exclusion criteria: 
1. A current diagnosis of psychosis or any other degenerative neurological condition, for 
example dementia or Parkinson’s disease. 
Seventy-five participants with progressive MS participated in the study.  Information 
about the number of participants approached by the clinicians was unavailable but four 
additional participants registered an interest but then decided not to participate in the study.  
Participants were recruited between March 2013 and March 2015 from the MS specialist 
rehabilitation clinic (n = 70) and between August 2014 and March 2015 (n = 5) from the MS 
clinic in the acute hospital.   
MS clinic staff identified those who met the inclusion criteria from a clinic database 
and invited them to participate in the research.  Prospective participants were given an 
information sheet about the study and all participants were given at least 48 hours to consider 
their participation.  The participant information sheet informed participants that they were 
being invited to take part in a study investigating negative thoughts, feelings and disability in 
MS.  It explained that they would be asked questions about depression and thoughts of 
harming themselves which might be upsetting.  It was also explained that if the researcher 
had concerns that the participant was at risk of harming themselves then clinic staff and their 
general practitioner would be informed.   The opportunity to discuss the study in further 
detail with a researcher before providing consent was also offered. 
Measures 
The Beck Suicide Scale (BSS) (Beck & Steer, 1993) was used to measure suicide 
ideation.  The highest total possible score is 42 and the higher the score the higher the level of 
suicide ideation.   
Beck Depression Inventory (BDI-II) (Beck, Steer & Brown, 1996) was used to 
measure depressive symptoms.  The highest total possible score is 63 and the higher the score 
the higher the level of depressive symptoms.  There are clinical cut off points to categorise 
the level of depression: mild = 14-19, moderate = 20-28. Severe = 29-63 (Beck, Steer & 
Brown, 1996).    
Multiple Sclerosis Impact Scale (MSIS-29) (Hobart, Lamping, Fitzpatrick, Riazi & 
Thompson, 2001) was used to measure perceived disability assessing how much the 
respondent is ‘bothered’ by specific types of disability.  The highest total possible score is 
145, the higher the score the higher the level of disability.  Perceived physical impact is 
assessed in 20 questions (highest possible score: 100) and perceived psychological impact is 
assessed in 9 questions (highest possible score: 45).   
Guys Neurological Disability Scale (GNDS) (Sharrack & Hughes, 1999) was used to 
measure actual disability, the highest total possible score is 60.   
All measures have been used previously in MS research.  Each measure was chosen 
based upon its clinical relevance, applicability and robust psychometric properties. 
 
Procedure 
 Data collection was carried out either at the MS clinic or at the participant’s own 
home.  Demographic data was collected followed by a set of questions asking about type of 
MS, any history of depression and/or suicidality, wheelchair and catheter use, medication use, 
alcohol use and any comorbid conditions.  Four measures were then utilised assessing: 
suicide ideation, depression, perceived disability and actual disability, in that order.  Many 
participants had visual difficulties and so each question was read out by the researcher.  One 
participant with a hearing impairment required the use of an interpreter.  All other 
participants completed the measures independently in the presence of the researcher.    
Following completion of the suicide ideation measure, if any suicidal thoughts were 
disclosed a thorough risk assessment was completed by the researcher, including clinical 
questions used to determine the level of suicide ideation and whether the participant had 
formulated a plan to take their own life.  When there was an immediate concern, the 
participant was not left alone and a duty psychiatrist was contacted via the participant’s 
general practitioner (GP) and requested to visit the participant.  When there was concern but 
not of such an immediate level, the respective clinic was informed on the same day and a 
decision was made as to whether to contact the participant’s GP and/or make a referral for 
talking therapy.  A referral for the latter was offered to 13 participants.  One participant was 
already receiving therapeutic support.   
Data analysis 
The main analysis was a mediation model (Preacher & Hayes, 2008; Preacher & 
Hayes, 2004).  Data from the BSS and BDI-II were not normally distributed and scores from 
the MSIS-29 and GNDS were normally distributed.   
In order to explore the relationship between disability, depressive symptoms and 
suicide ideation, mediation analysis procedures were used to examine the potential mediating 
effects of depressive symptoms (Preacher & Hayes, 2008; Preacher & Hayes, 2004).  This 
particular strategy reports bias corrected bootstrap confidence intervals which are robust to 
violation of parametric inference assumptions and therefore overcomes the problem of non-
normality as described above and provides robust confidence intervals in smaller sample 
situations (Hardle & Marron, 1991; Moore & McCabe, 2005).  Furthermore, given this is a 
clinical population, it cannot be assumed that the reference population itself has a normal 
distribution of scores so the decision was taken that it would be inappropriate to correct the 
sample distributions for normality.   
Prior to the analysis, in order to standardise the regression parameters and to enable 
direct comparison between parameter coefficients within the mediation model, all of the 
variables were transformed into z scores (M = 0, SD = 1).   
Results 
The sample consisted of 31 males and 44 females, with an average age of 55 years 
(SD = 10.08, range: 38-79).  The average age of onset was 33 years (SD = 11.62, range: 13-
68) and the average time since onset was 23 years (SD = 12.48, range: 5-55).   
There were 52 participants living with a spouse/partner/or other relative and 11 were 
in full or part time paid work.  Twenty six participants had a diagnosis of primary progressive 
MS (PPMS) and 49 had a diagnosis of secondary progressive MS (SPMS).  Sixty two 
reported using a wheelchair either continuously or for community access and 35 used either a 
permanent or temporary catheter.  One participant was taking disease modifying medication.  
There were 15 participants with co-morbid physical health conditions (for example asthma, 
high blood pressure, underactive thyroid) including three who had experienced a mild stroke 
more than six months ago.   
Fifteen participants reported using prescribed anti-depressant medication with 47 
disclosing a history of depression and five describing a history of other mental health 
problems.  Eight participants reported current or past alcohol misuse.  Eleven participants 
disclosed previous suicide ideation and, when asked if suicide had ever been attempted in the 
past, seven participants reported at least one or more attempt.  One participant disclosed 11 
previous attempts, the first of which followed the diagnosis of MS. 
Following the same procedure described by Crane, Shah, Barnhofer and Holmes 
(2012), participants were split into two groups according to their BSS score: 49 participants 
reported no suicide ideation as defined by a BSS score of zero and 26 reported some level of 
suicide ideation defined as a BSS score greater than or equal to one.   The mean score for 
depressive symptoms for all participants fell in the clinical category of ‘mild’ according to 
Beck, Steer & Brown (1996).  The numbers of participants in each clinical category were: 
minimal n= 37, mild n= 21, moderate n= 11 and severe n= 6.  Table I shows descriptive 
statistics for each measure including the Cronbach’s alpha calculated from the study data.  
Table I. Measures of central tendency and internal reliability for all measures 
Measure M SD Mdn Mode Range Cronbach’s 
alpha 
BSS (max score 42) 2.44 5.67 0.00 0.00 0.00-35.00 0.93 
BDI-II (max score 63) 13.8 8.88 13.00 9.00 0.00-39.00 0.88 
MSIS-29 (max score 
145) 
86.75 25.36 88.00 71.00 14.00-22.00 0.93 
MSIS 
(physical subscale) 
(max score 100) 
64.71 19.27 65.00 46.00 0.00-96.00 0.91 
MSIS 
(psychological 
subscale) (max score 
45) 
21.91 8.32 20.00 19.00 9.00-41.00 0.85 
GNDS (max score 60) 24.73 8.92 24.00 23.00 1.00-49.00 0.71 
 
As can be seen from table 1, good internal reliability was found for all measures.  
Do depressive symptoms mediate the relationship between perceived disability and suicide 
ideation? 
 Table II below displays the outcomes of the mediation analysis for perceived 
disability and Figure 1 below displays the mediation model.   
Table II.  Mediated relationship between depression, perceived disability and suicide ideation 
  Path 
Estimate β  
Standard 
Error SE 
p value Lower 95% 
Bootstrap 
Confidence 
Interval 
Upper 95% 
Bootstrap 
Confidence 
Interval 
 
Correlation between perceived disability and 
suicide ideation in the unmediated model 
0.42 0.16 0.014 0.09 0.74 
Correlation between perceived disability and 
suicide ideation in the mediated model  
0.10 0.11 0.399 -0.13 0.33 
Depression as mediator  0.32 0.15 NA 0.12 0.73 
Path from perceived disability to depression 0.66 0.10 0.001 0.46 0.87 
 Path from depression to suicidal ideation 0.48 0.22 0.029 0.05 0.91 
 
 
 
Figure 1. The mediating effect of depressive symptoms upon perceived disability and suicide 
ideation 
In the unmediated model, the effect of perceived disability on suicide ideation was 
positive and significant (β = 0.42, SE = 0.16, p=0.014).  This was reduced when the 
mediating effect of depressive symptoms was included in the analysis (β =0.10, SE = 0.11, p 
= 0.399), accounting for approximately 32% of the original relationship between perceived 
disability and suicide ideation.  Significant path coefficients were reported for both the path 
to the mediator variable (β = 0.66, SE = 0.10, p = 0.001) and from the mediator variable to 
suicide ideation (β = 0.48, SE = 0.22, p = 0.029).  Accordingly, a complete mediation effect 
was observed.   
 Depressive symptoms 
Suicide ideation Perceived disability 
  
 
 
β =0.48  β =0.66 
β =0.10 
Do depressive symptoms mediate the relationship between actual disability and suicide 
ideation? 
Table III below displays the outcomes of the mediation analysis for disability and 
Figure 2 displays the hypothesised model.   
 
Table III.  Mediated relationship between depression, perceived disability and suicide 
ideation 
  Path 
Estimate β  
Standard 
Error SE 
p value Lower 95% 
Bootstrap 
Confidence 
Interval 
Upper 95% 
Bootstrap 
Confidence 
Interval 
 
Correlation between perceived disability and 
suicide ideation in the unmediated model 
0.36 0.18 0.047 0.04 0.72 
Correlation between perceived disability and 
suicide ideation in the mediated model  
0.05 0.11 0.631 -0.13 
 
0.28 
Depression as mediator  0.31 0.12 NA 0.13 0.61 
Path from perceived disability to depression 0.60 0.10 0.001 0.41 0.80 
 Path from depression to suicidal ideation 0.51 0.19 0.008 0.14 0.89 
 
 
Figure 2. The mediating effect of depressive symptoms upon disability and suicide ideation 
In the unmediated model, the effect of perceived disability on suicide ideation was 
positive and significant (β = 0.36, SE = 0.18, p=0.047).  This was reduced when the 
mediating effect of depressive symptoms was included in the analysis (β =0.05, SE = 0.11, p 
= 0.631), accounting for approximately 31% of the original relationship between perceived 
disability and suicide ideation.  Significant path coefficients were reported for both the path 
 Depressive symptoms 
Suicide ideation        Disability 
  
 
 
β =0.60  β =0.51  
β =0.05  
 
to the mediator variable (β = 0.60, SE = 0.10, p = 0.001) and from the mediator variable to 
suicide ideation (β = 0.51, SE = 0.19, p = 0.008).  Accordingly, a complete mediation effect 
was observed.   
Is any specific type of disability related to suicide ideation? 
As distributions for disability measures were consistent with parametric assumptions, 
a series of independent-sample t-tests were carried out to identify whether high or low suicide 
ideation groups are associated with specific disability. As explained earlier, participants were 
categorised as either: no suicide ideation (a score of 0 on the BSS, n = 49); or suicide ideation 
(a score ≥1 on the BSS, n = 26).   
When comparing differences between groups on the physical subscales of the MSIS-
29 which measured perceived disability, significant differences were found for: ‘moving 
about indoors’, t(73) = -1.90, p< .05, no suicide ideation group (M = 0.98, SD = 1.66), suicide 
ideation group (M = 3.69, SD = 1.29); tremors, t(73) = -1.74, p< .05, no suicide ideation 
group (M = 2.33, SD = 1.30) suicide ideation group (M = 2.92, SD = 1.62); ‘taking longer to 
do things’ t(73) = -1.80, p≤ .01, no suicide ideation group (M = 3.10, SD = 1.57) and suicide 
ideation group (M = 3.73, SD = 1.15).   
On the psychological subscales of the MSIS-29 significant differences were found 
between groups on: ‘problems sleeping’, t(73) = -1.52, p< .05, no suicide ideation group (M = 
2.00, SD = 1.24) suicide ideation group (M = 2.50, SD = 1.56); ‘anxiety and tension’, t(73) = 
-1.70, p≤ .01, no suicide ideation group (M = 2.16, SD = 1.26), suicide ideation group (M = 
2.73, SD = 1.56), and ‘feeling depressed’, t(73) = -2.99, p< .01, no suicide ideation group (M 
= 1.69, SD = 2.54), suicide ideation group (M = 2.54, SD = 1.48).    
No significant differences were found between the no suicide ideation and suicide 
ideation groups when comparing types of actual disability based upon the GNDS.   
Is there a sub-group of individuals who report suicide ideation with only a minimal or mild 
level of depressive symptoms? 
Participants were split into those with a BSS score of zero versus above zero as 
described above, and a BDI score either above or below 19, below 19 indicating minimal or 
mild depressive symptoms (Beck, Steer & Brown, 1996).  Twelve participants reported 
suicidal ideation in the presence of moderate or more marked depression, 14 reported suicidal 
ideation but were not depressed or had very mild symptoms, four reported no ideation in the 
presence of moderate or more marked depression and 45 were neither depressed or reported 
suicidal ideation.  This suggests an absolute risk of suicidal ideation in none or mildly 
depressed participants of 0.24 (95% CI 0.13 to 0.35), which rises to 0.75 (95% CI 0.54 to 
0.96) in their depressed counterparts.  Thus just fewer than 25% of participants who were not 
depressed experienced some suicidal ideation. The relative risk ratio of suicidal ideation in 
those who were depressed was 3.16 (95% CI 1.85 to 5.41), suggesting that depressed 
participants were a little over three times more likely to experience suicidal ideation than 
those who had no or minimal depression.   
Discussion 
The present study investigated the relationship between three variables: disability, 
depression and suicide ideation in progressive MS.  The main aim of the study was to explore 
the relationship between all three variables using a mediation model, including a measure of 
perceived and actual disability.  The study also aimed to find out whether different types of 
disability were associated with suicide ideation and if there were a sub-group of participants 
who disclosed suicide ideation with only a minimal or mild level of depressive symptoms.  
Very little previous research has examined depression, suicide or the relationship between the 
two in progressive MS.  Therefore the findings of this research provide a novel contribution 
to the literature. 
  The prevalence of suicidality was 35% which is slightly higher than the findings of 
Feinstein (2002) and Turner et al. (2006) who did not use a standardised suicide ideation 
measure.  The overall mean total BDI-II score was found to be similar to that of participants 
in other MS studies for example Pujol et al. (2000).  The observed scores on the MSIS-29 
physical and psychological subscales were also found to be similar to previous studies on 
similar populations, for example Motl, Suh, and Weikert (2010); as were the GNDS scores 
for example Nicholl, Lincoln, Francis, and Stephan (2001). 
Depressive symptoms were found to mediate the relationship between perceived 
disability and suicide ideation.  This is a new finding and it is the first time it has been 
investigated in MS.  It is consistent with the findings of Meltzer et al. (2012) who found that 
the relationship between limitations of daily living activities in adults from the general 
population and suicidality were mediated by depression.  In the present study we have 
extended this to show that in MS, a direct relationship exists between actual disability and 
depressive symptoms, as well as perceived disability and suicide ideation.  The latter finding 
is similar to the study by Turner et al. (2006) who also found a direct relationship between 
perceived disability and suicide ideation in a sample of veterans who had received services 
for MS in the United States of America.  It seems that there is still a lack of research 
investigating the impact of perceived disability in MS despite Turk et al. (1995) advocating 
for its use in disability research generally.  In the present study at least 30% of the direct 
relationship between perceived disability and suicide ideation was accounted for by 
depressive symptoms, highlighting the need to have an open discussion with patients about 
the degree to which they are distressed by their symptoms, as well as the actual impact of 
symptoms and the need to target interventions to alleviate distress and hence reduce the risk 
of suicide.   For example, in a systematic review and meta-analysis of seven studies exploring 
the use of cognitive behavioural therapy (CBT) for depression in MS, Hind, Cotter, Thake, 
Bradburn, Cooper, Isaac and House, (2014) found a medium size treatment effect for CBT 
when compared mainly with those who received ‘standard care’, were waiting list controls or 
received other supportive therapy.  
Depressive symptoms were also found to mediate the relationship between actual 
disability and suicide ideation.  Again, this is a new finding which has not been investigated 
in MS before.  Consistent with the findings of Meltzer et al. (2012) depressive symptoms had 
an indirect effect upon the direct relationship between actual disability and suicide ideation in 
MS.  In the present study, depressive symptoms accounted for at least 30% of the 
relationship.  They are a modifiable contributory factor to suicide ideation and therefore need 
to be addressed.  Finding a significant direct relationship between actual disability and 
depressive symptoms has mirrored the findings of several other studies in this population, 
most recently the study by Smith and Arnett (2013).  The finding of a significant relationship 
between depressive symptoms and suicide ideation has added to the few studies in this area 
that have reported similar findings (Turner et al., 2006; Viner et al., 2014). 
Based on the commonly used measure, the GNDS, no differences were found between 
individuals with and without suicide ideation in terms of types of actual disability.  However, 
there were several differences for perceived disability based upon the MSIS-29 namely: 
‘moving about indoors’, ‘tremors’, ‘taking longer to do things’ and ‘difficulty doing things 
spontaneously’ for the physical subscale; ‘problems sleeping’, ‘anxiety and tension’ and 
‘feeling depressed’ for the psychological subscale.  Whilst the psychological symptoms are 
clearly linked to suicide ideation through the mediating effect of depression, the physical 
symptoms may require greater attention from clinicians as potential risk factors.  Tremors 
have been referred to as one of the most physically disabling manifestations of MS 
(Thompson et al., 2001) and our findings confirm that they are a source of particular distress 
that may be associated with suicide ideation.  Previous studies addressing this issue have used 
non-validated measures of disability and found that problems with mobility (Turner et al., 
2006), bladder and bowel functioning (Turner et al., 2006; Viner et al., 2014) and 
communication and swallowing difficulties (Viner et al., 2014) were associated with suicide 
ideation.  As there are few studies investigating the perceived impact of symptoms as risk 
factors for suicide ideation, further investigation is required in this area. 
Finally, the present study identified that there was a sub-group of individuals who 
reported suicide ideation with only a minimal or mild level of depressive symptoms.  As the 
inclusion of the mediated variable between disability and suicide ideation meant that the path 
estimate reduced to not quite zero, for both perceived and actual disability, it could be 
suggested that the residual amount accounted for the sub-group of participants who reported 
suicide ideation but only a minimal or mild level of depression.  With some cautiousness, this 
finding could support the notion of ‘rational’ suicide, wherein, as suggested by Onkay-Ho 
(2014), suicide might be seen as a way of managing the condition, possibly to gain a sense of 
mastery (Siegel & Meyer, 1999).  Findings of the present study could also be in agreement 
with Gaskill et al. (2011), who suggested that perceived loss of control is the major disease-
related variable associated with suicide ideation in MS.  However, it is also important to note 
that although participants experiencing active psychosis or any other degenerative 
neurological conditions were excluded from the study, people with other comorbid 
psychiatric disorders such as anxiety were not excluded and these conditions could be 
potential reasons for suicide ideation, as could other factors such as substance misuse or 
psychosocial stressors.  Further research is therefore required in this area. 
The present study has identified several important factors which require consideration 
in the context of clinical management of MS.  The relationship found between all three 
variables (disability, depressive symptoms and suicide ideation) suggests that it is particularly 
important to screen for depression in those with more severe disability.  Depression is a 
modifiable factor in MS which can be treated effectively with antidepressants (Arciniegas & 
Anderson, 2002) or psychological therapy and if not ameliorated can lead to suicidality 
(Paparrigopoulos et al., 2010; Raskind, 2008).  Additionally, the findings of this study have 
highlighted that individuals with suicide ideation may not be detected via depression 
screening, an important implication for clinicians when screening in the future.  It is notable 
that suicidal behaviour in the general population has been conceptualised as existing on a 
continuum from suicide ideation, to formulation of a plan, to attempted or completed suicide 
(Kessler, Berglund, Borges, Nock & Wang, 2005).  Thus clinicians need to feel confident to 
ask patients whether they are experiencing any thoughts about harming themselves and also 
remain aware of the types of perceived disabilities associated with suicide ideation.  
Limitations 
 All participants in the present study were attending MS outpatient clinics for review 
appointments and/or rehabilitation support.  There may thus be a sample bias as those 
attending clinics could be either suffering more symptoms/distress or in receipt of services 
that are reducing symptoms/distress.  Also, previous research has suggested that higher levels 
of suicide ideation are present within the first year after diagnosis (Fredrikson et al., 2002), 
possibly continuing into the following four years (Bronnum-Hansen et al., 2005), whereas no 
participants in the present study had been diagnosed for less than five years.  Information was 
not obtained about the number of potential participants approached, declined or ineligible.  
Rates of depressive symptoms and suicide ideation in this sample group could therefore be 
under representative of the whole MS populaiton.  Furthermore, some participants (n = 15) 
were taking antidepressants which could have reduced depressive symptoms and suicide 
ideation.  Finally, the MSIS-29 and GNDS did not measure equivalent items and thus the 
differences in perceived and actual disability could reflect the range of items, although items 
such as tremors and taking longer to do things could be considered to be implicit in GNDS  
items measuring problems using arms and hands.  Unfortunately there is no available 
validated measure that includes both viewpoints.  
Conclusion 
Suicide ideation in MS is potentially a treatable cause of both morbidity and mortality 
(Feinstein, 1997; 2002).  Given that suicide ideation is associated with an increased risk for 
making plans, attempting suicide and completing suicide (Kessler et al., 2005; Nock et al., 
2008), regular screening in clinical practice alongside further research in this area is 
imperative, especially taking into consideration the impact of perceived disability and the 
concept of ‘rational’ suicide.  For those who disclose minimal or mild levels of depression it 
cannot be assumed that there is no suicide risk.   
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